Data-driven Enhancement of Diversity in Clinical Trials: Making Clinical Trials Equitable to ALL

Mon, Aug 5, 2:00 PM - 3:50 PM

Biopharmaceutical Section

3 Presentations

2:05 PM - 2:25 PM

Christine S Lee (U.S. Food and Drug Administration)

2:25 PM - 2:45 PM

2:45 PM - 3:05 PM

Laura Fernandes (COTA Healthcare Inc.)

Co-authors: Karla Feghali (Deloitte)

Kannan Natarajan (Pfizer)